Cipla Ltd up by 2% on announcement of `ViraGen` for COVID-19 By Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below are Quote on Cipla Ltd up by 2% on announcement of ‘ViraGen’ for COVID-19 by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
ViraGen used for qualitative detection of SARS-CoV-2 will be manufactured by Ubio Biotechnology Systems and marketed and distributed by Cipla through its expansive distribution network across the country.
This is a good launch for Cipla limited but as of now Covid 19 cases in India have started coming down in the 2nd wave. We don’t expect this product to make a major contribution to the top line of the company. We have a neutral rating on Cipla Limited.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
